$327 Million is the total value of Samsara BioCapital, LLC's 41 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 25.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MINERALYS THERAPEUTICS INC | $42,979,123 | -44.2% | 4,519,361 | 0.0% | 13.16% | -2.7% | ||
| New | RAYZEBIO INC | $40,980,046 | – | 1,845,948 | +100.0% | 12.54% | – | |
| SRRK | SCHOLAR ROCK HLDG CORP | $32,651,679 | -5.8% | 4,598,828 | 0.0% | 10.00% | +64.2% | |
| Buy | ACELYRIN INC | $24,220,658 | -48.6% | 2,381,579 | +5.6% | 7.41% | -10.4% | |
| ARCELLX INC | $22,027,485 | +13.5% | 613,921 | 0.0% | 6.74% | +97.9% | ||
| GRPH | GRAPHITE BIO INC | $20,979,099 | -4.6% | 8,459,314 | 0.0% | 6.42% | +66.4% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $11,878,356 | +67.6% | 640,688 | 0.0% | 3.64% | +192.3% | |
| LYRA | LYRA THERAPEUTICS INC | $10,870,821 | -4.9% | 2,780,261 | 0.0% | 3.33% | +65.9% | |
| Buy | HILLEVAX INC | $10,750,235 | +4.4% | 799,274 | +33.4% | 3.29% | +82.0% | |
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $9,965,528 | -37.5% | 967,527 | 0.0% | 3.05% | +9.0% | |
| ZYMEWORKS INC | $9,249,268 | -26.6% | 1,458,875 | 0.0% | 2.83% | +28.0% | ||
| RYTM | RHYTHM PHARMACEUTICALS INC | $7,915,842 | +39.0% | 345,293 | 0.0% | 2.42% | +142.5% | |
| TANGO THERAPEUTICS INC | $7,093,800 | +239.2% | 630,000 | 0.0% | 2.17% | +491.6% | ||
| INZY | New | INOZYME PHARMA INC | $6,562,500 | – | 1,562,500 | +100.0% | 2.01% | – |
| STRO | SUTRO BIOPHARMA INC | $5,814,259 | -25.4% | 1,675,579 | 0.0% | 1.78% | +30.1% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $5,664,250 | -22.9% | 347,500 | 0.0% | 1.73% | +34.5% | |
| Buy | IO BIOTECH INC | $5,132,421 | +160.3% | 3,640,015 | +261.0% | 1.57% | +354.0% | |
| GOSS | New | GOSSAMER BIO INC | $5,105,287 | – | 6,130,268 | +100.0% | 1.56% | – |
| ACRS | ACLARIS THERAPEUTICS INC | $4,768,771 | -33.9% | 696,171 | 0.0% | 1.46% | +15.2% | |
| IMTX | IMMATICS N.V | $4,585,680 | +0.3% | 396,000 | 0.0% | 1.40% | +75.1% | |
| PRIME MEDICINE INC | $4,486,700 | -34.9% | 470,304 | 0.0% | 1.37% | +13.6% | ||
| IMCR | IMMUNOCORE HLDGS PLCads | $4,201,980 | -13.4% | 80,963 | 0.0% | 1.29% | +50.9% | |
| NKTX | NKARTA INC | $3,986,569 | -36.5% | 2,868,035 | 0.0% | 1.22% | +10.7% | |
| JANX | JANUX THERAPEUTICS INC | $3,632,973 | -15.1% | 360,414 | 0.0% | 1.11% | +48.1% | |
| SYROS PHARMACEUTICALS INC | $3,481,728 | +25.4% | 881,450 | 0.0% | 1.07% | +118.9% | ||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $3,451,680 | -8.2% | 432,000 | 0.0% | 1.06% | +60.2% | |
| PEPGEN INC | $3,307,334 | -43.2% | 651,050 | 0.0% | 1.01% | -1.0% | ||
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $2,410,135 | +2.8% | 196,425 | 0.0% | 0.74% | +79.1% | |
| RAIN | RAIN ONCOLOGY INC | $1,753,377 | -28.2% | 2,034,552 | 0.0% | 0.54% | +25.2% | |
| IGMS | IGM BIOSCIENCES INC | $1,291,444 | -9.5% | 154,664 | 0.0% | 0.40% | +57.4% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,091,119 | -18.8% | 1,049,153 | 0.0% | 0.33% | +41.5% | |
| TERN | TERNS PHARMACEUTICALS INC | $1,017,810 | -42.5% | 202,348 | 0.0% | 0.31% | +0.3% | |
| LEAP THERAPEUTICS INC | $831,040 | -55.9% | 602,203 | 0.0% | 0.25% | -23.3% | ||
| VTVT | VTV THERAPEUTICS INCcl a | $781,773 | -35.4% | 1,635,509 | 0.0% | 0.24% | +12.7% | |
| VIRX | VIRACTA THERAPEUTICS INC | $717,297 | -26.2% | 689,709 | 0.0% | 0.22% | +28.7% | |
| ALLK | ALLAKOS INC | $390,642 | -47.9% | 172,089 | 0.0% | 0.12% | -9.1% | |
| SCIENCE 37 HOLDINGS INC | $360,000 | +88.2% | 900,000 | 0.0% | 0.11% | +223.5% | ||
| ALVR | ALLOVIR INC | $177,022 | -36.8% | 82,336 | 0.0% | 0.05% | +10.2% | |
| KRON | KRONOS BIO INC | $101,570 | -24.4% | 78,131 | 0.0% | 0.03% | +29.2% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $13,333 | -39.5% | 133,333 | 0.0% | 0.00% | 0.0% | |
| SURROZEN INC*w exp 08/01/203 | $4,110 | -25.5% | 99,999 | 0.0% | 0.00% | 0.0% | ||
| NVAX | Exit | NOVAVAX INC | $0 | – | -21,244 | -100.0% | -0.03% | – |
| Exit | ASTRIA THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.04% | – | |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -883,720 | -100.0% | -0.07% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -1,788,280 | -100.0% | -0.17% | – |
| ELEV | Exit | ELEVATION ONCOLOGY INC | $0 | – | -830,565 | -100.0% | -0.22% | – |
| DBTX | Exit | DECIBEL THERAPEUTICS INC | $0 | – | -801,629 | -100.0% | -0.54% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -202,773 | -100.0% | -1.65% | – | |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -308,151 | -100.0% | -2.13% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -5,161,888 | -100.0% | -34.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.